[Taylor&Francis] Is IMvigor011 a conventional adjuvant trial or a ctDNA-triggered preemptive treatment strategy? |
|
This post will be closed automatically in 2026-10-24 23:01
Reward30points
|
post
reply
points
3021
30
Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis
50
[Full book]Discounting for Time and Risk in Energy Policy
30
[Single chapter]India Higher Education Report 2025 chapter 9 (Multidisciplinary Liberal Higher Education Opportunities and Challenges from a Governance and Leadership Perspective)
30
Is IMvigor011 a conventional adjuvant trial or a ctDNA-triggered preemptive treatment strategy?
50
[Full book]Narratives in Public Communication
